Black Rock Inc. Ptc Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 7,772,140 shares of PTCT stock, worth $392 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,772,140
Previous 7,565,086
2.74%
Holding current value
$392 Million
Previous $220 Million
8.0%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding PTCT
# of Institutions
257Shares Held
77.3MCall Options Held
179KPut Options Held
536K-
Vanguard Group Inc Valley Forge, PA9.18MShares$462 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$372 Million5.44% of portfolio
-
Armistice Capital, LLC New York, NY6.38MShares$321 Million4.07% of portfolio
-
Wellington Management Group LLP Boston, MA4.79MShares$241 Million0.04% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A63.29MShares$166 Million0.24% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.6B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...